Your session is about to expire
← Back to Search
Acetic Acid Supplement
Rice Vinegar as an Intervention to Lower Blood Pressure in Adults With Prehypertension and 10-year CVD Risk <10% (Rice-vinegar Trial)
N/A
Waitlist Available
Led By Lydia Bazzano, MD, PhD
Research Sponsored by Mizkan Holdings Co., Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 4, 8, 12, and 16
Summary
This trial is testing a rice vinegar drink to see if it can lower blood pressure in adults aged 30-65 with prehypertension. The drink contains acetic acid, which might help reduce blood pressure. Participants will consume the drink over a few months and have their blood pressure monitored regularly.
Eligible Conditions
- Hypertension
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weeks 4, 8, 12, and 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 4, 8, 12, and 16
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Systolic Blood Pressure
Secondary study objectives
Changes in Corresponding Blood Biomarkers
Changes in Diastolic Blood Pressure
Changes in Vascular Reactivity via VENDYS®
Other study objectives
Assessment of Adverse Events
Changes in Body Weight and BMI
Changes in Dietary Intake
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Mizkan rice vinegar with acetic acidExperimental Treatment1 Intervention
200mL serving of a fruit-flavored beverage containing diluted Mizkan rice vinegar and 750mg acetic acid.
Group II: Mizkan rice vinegar without acetic acidPlacebo Group1 Intervention
200mL serving of a fruit-flavored beverage containing diluted Mizkan rice vinegar that has undergone a freeze-drying process to remove the acetic acid
Find a Location
Who is running the clinical trial?
EndothelixUNKNOWN
ObvioHealthIndustry Sponsor
11 Previous Clinical Trials
11,022 Total Patients Enrolled
Mizkan Holdings Co., Ltd.Lead Sponsor
1 Previous Clinical Trials
24 Total Patients Enrolled
Lydia Bazzano, MD, PhDPrincipal InvestigatorTulane University